Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 147
Genomics 73
Biopharmaceuticals 73
Immune Disorders Drugs 70
Biotechnology 50
Pharmaceuticals 41
Musculoskeletal Disorders Drugs 41
Oncology Drugs 40
Drug Discovery 37
Hematological Drugs 36
Biosimilars and Biosuperiors 31
Alzheimer's Disease Drugs 26
Infusions and Injectables 24
Allergy and Immunology 23
Cardiovascular Drugs 23
Optical Disorders Drugs 21
Clinical Trials 21
Mental Disorders Drugs 19
Neurology 18
Needles and Syringes 16
E-Healthcare 14
Respiratory Drugs 14
Psoriasis Drugs 14
Optical 13
Immunosuppressive Drugs 13
Gastrointestinal Drugs 12
Healthcare Services 11
Infectious Diseases Drugs 11
Analgesics 11
Hematology 11
Drug Delivery 10
Endocrine and Metabolic Disorders Drugs 10
Pharmaceutical Manufacturing 10
Lymphoma Drugs 9
Diagnostics 9
Drugs by Therapeutic Area 8
Leukemia Drugs 8
Therapeutic Area 7
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Medical Devices 6
Enzymes 5
Neurology Devices 5
Oncology 5
Schizophrenia Drugs 5
Company Reports 4
Proteomics 4
Mental Health 4
Gastroenterology 4
Cardiology 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Hospital Management 3
Dermatology 3
Vitamins and Dietary Supplements 3
Dermatological Drugs 3
Urology and Nephrology 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Laboratory Equipment 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Lung Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Surgical Devices 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Palliative Care 1
Pediatrics 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

850 Results (Page 15 of 43)
- Relevance
  Sort by

Rare Diseases Market Report 2024-2034

 Report
May 2024
344 Pages
Global

From

€5319EUR$5,963USD£4,350GBP

Canada Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
77 Pages
Canada

From

€3093EUR$3,350USD£2,618GBP

Systemic Psoriasis Therapeutics - Global Strategic Business Report

 Report
October 2026
192 Pages
Global

From

€5401EUR$5,850USD£4,572GBP

Autoinjectors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

 Report
October 2021
100 Pages
Global

From

€4155EUR$4,500USD£3,517GBP

Dermatology Collaboration and Licensing Deals 2016-2026

 Report
October 2026
300 Pages
Global

From

€3689EUR$3,995USD£3,122GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
295 Pages
Global

From

€2308EUR$2,500USD£1,954GBP

Global Biosimilars Partnering Terms and Agreements 2010 to 2023

 Report
June 2023
150 Pages
Global

From

€3689EUR$3,995USD£3,122GBP

Red Biotechnology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
June 2025
185 Pages
Global

From

€4155EUR$4,500USD£3,517GBP

Crohn's Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
120 Pages
Global

€4612EUR$4,995USD£3,904GBP

IV Fluid Transfer Drugs Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
102 Pages
Global

From

€3500EUR$4,061USD£3,066GBP

Immunomodulators - Global Strategic Business Report

 Report
October 2026
280 Pages
Global

From

€5401EUR$5,850USD£4,572GBP

Hodgkins Lymphoma Treatment - Global Strategic Business Report

 Report
October 2026
127 Pages
Global

From

€5401EUR$5,850USD£4,572GBP

Rare Hematology Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
November 2023
113 Pages
Global

From

€3500EUR$4,061USD£3,066GBP

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

 Report
November 2023
63 Pages
Global

€8560EUR$9,595USD£7,000GBP

Biotechnology Market Size, Share & Trends Analysis Report By Technology (Nanobiotechnology, DNA Sequencing, Cell-based Assays), By Application (Health, Bioinformatics), By Region, And Segment Forecasts, 2023 - 2030

 Report
May 2023
180 Pages
Global

From

€5494EUR$5,950USD£4,650GBP

HPV Associated Disorders Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4146EUR$4,490USD£3,509GBP

Leukemia Therapeutics - Global Strategic Business Report

 Report
October 2026
193 Pages
Global

From

€5401EUR$5,850USD£4,572GBP

Red Biotechnology Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

 Report
May 2026
350 Pages
Global

From

€4570EUR$4,949USD£3,868GBP

Antibody Discovery Market Industry Trends and Global Forecasts to 2035: Distribution by Antibody Discovery Step, Antibody Discovery Method, Nature of, Type of Antibody, Therapeutic Area, End-user and Geographical Regions

 Report
June 2025
607 Pages
Global

From

€4431EUR$4,799USD£3,750GBP

Diagnostic Imaging Collaboration and Licensing Deals 2016-2026

 Report
May 2026
400 Pages
Global

From

€3689EUR$3,995USD£3,122GBP

850 Results (Page 15 of 43)
- 1
- 13
- 14
- 15
- 16
- 17

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.